SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001193805-19-000388
Filing Date
2019-04-22
Accepted
2019-04-22 17:03:33
Documents
1

Document Format Files

Seq Description Document Type Size
1 e618384_sc13d-immunic.htm SC 13D 33220
  Complete submission text file 0001193805-19-000388.txt   34739
Mailing Address AM KLOPFERSPITZ 19 MARTINSRIED 2M 82152
Business Address AM KLOPFERSPITZ 19 MARTINSRIED 2M 82152 49 89 250079460
IMMUNIC, INC. (Subject) CIK: 0001280776 (see all company filings)

IRS No.: 562358443 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-88651 | Film No.: 19760002
SIC: 2834 Pharmaceutical Preparations

Mailing Address KANTSTRABE 5 MAGDEBURG 2M 39104
Business Address KANTSTRABE 5 MAGDEBURG 2M 39104 49 172 6650655
IBG Risikokapitalfonds II GmbH & Co. KG (Filed by) CIK: 0001774292 (see all company filings)

IRS No.: 000000000 | State of Incorp.: 2M | Fiscal Year End: 1231
Type: SC 13D